0000899243-20-004781.txt : 20200214 0000899243-20-004781.hdr.sgml : 20200214 20200214210233 ACCESSION NUMBER: 0000899243-20-004781 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200212 FILED AS OF DATE: 20200214 DATE AS OF CHANGE: 20200214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ginn Scott G CENTRAL INDEX KEY: 0001543701 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24260 FILM NUMBER: 20623043 MAIL ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMEDISYS INC CENTRAL INDEX KEY: 0000896262 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 113131700 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 BUSINESS PHONE: 2252922031 MAIL ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 FORMER COMPANY: FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP DATE OF NAME CHANGE: 19940819 FORMER COMPANY: FORMER CONFORMED NAME: M&N CAPITAL CORP DATE OF NAME CHANGE: 19930125 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-12 0 0000896262 AMEDISYS INC AMED 0001543701 Ginn Scott G 3854 AMERICAN WAY, SUITE A BATON ROUGE LA 70816 0 1 0 0 Chief Financial Officer Common Stock 2020-02-12 4 M 0 7836 0.00 A 18534 D Common Stock 2020-02-12 4 F 0 906 198.81 D 17628 D Common Stock 2020-02-12 4 A 0 1258 0.00 A 18886 D Common Stock 2714 I Through 401(k) Plan Restricted Stock Unit (Performance-Based Vesting) 2020-02-12 4 M 0 3934 0.00 D Common Stock 3934 0 D Stock Option (Right to Buy) 198.81 2020-02-12 4 A 0 2997 0.00 A 2030-02-12 Common Stock 2997 2997 D Restricted Stock Unit (Performance-Based Vesting) 2020-02-12 4 A 0 2515 0.00 A Common Stock 2515 2515 D Includes 887 shares held in an employee stock purchase plan account. The Issuer awarded the Reporting Person 1,258 time-based Restricted Stock Units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest in equal, 25% installments on each of February 12, 2021, 2022, 2023 and 2024, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to certain pro-rated vesting provisions as provided in the award agreement for the RSUs. The information in this report is based on a plan statement dated as of December 31, 2019. On February 20, 2019, the Reporting Person was awarded performance-based RSUs with vesting provisions based on certification of achievement of an identified performance measure for 2019, with additional time-based vesting in equal 25% installments on each of the certification date and February 20, 2021, 2022 and 2023, assuming the Reporting Person remains continuously employed on the vesting date. The amount reported in a Form 4 filed on February 22, 2019 was 3,934 RSUs, which was the amount of shares payable at target performance; the Reporting Person was eligible to earn 50%-200% of the amount reported depending on the level of performance achieved. On February 12, 2020, the Compensation Committee of the Issuer's Board of Directors certified achievement of the 2019 performance measure at 199.2%, thereby resulting in the Reporting Person earning 7,836 RSUs, which are reported in Table I. The Stock Options are subject to time-based vesting conditions and will vest in equal, 25% installments on each of February 12, 2021, 2022, 2023 and 2024, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to pro-rated vesting provisions as provided in the award agreement for the Stock Options. The performance-based RSUs will vest based on certification of achievement of an identified performance measure for 2020, with additional time-based vesting in equal 25% installments on each of the certification date and February 12, 2022, 2023 and 2024, assuming the Reporting Person remains continuously employed on the vesting date. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 50%-200% of the amount reported depending on the level of performance achieved. /s/ Jennifer R. Guckert, pursuant to a power of attorney 2020-02-14